Zentalis Pharmaceuticals Share Price Today
(NASDAQ: ZNTL)
Zentalis Pharmaceuticals share price is $1.29 & ₹110.25 as on 18 Apr 2025, 2.30 'hrs' IST
$1.29
▲
0.03
(2.38%)
Market is closed - opens 7 PM, 21 Apr 2025
View live Zentalis Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Zentalis Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Zentalis Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.
Zentalis Pharmaceuticals share price movements
- Today's Low: $1.23Today's High: $1.34
4.65%
Downside
Day's Volatility :7.87%
Upside
3.37%
- 52 Weeks Low: $1.0152 Weeks High: $13.46
21.71%
Downside
52 Weeks Volatility :92.5%
Upside
90.42%
Zentalis Pharmaceuticals (ZNTL) Returns
Zentalis Pharmaceuticals (ZNTL) Key Statistics
in dollars & INR
How to invest in Zentalis Pharmaceuticals Stock (ZNTL) from India?
It is very easy for Indian residents to invest directly in Zentalis Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Zentalis Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Zentalis Pharmaceuticals or ZNTL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Zentalis Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Zentalis Pharmaceuticals shares which would translate to 0.663 fractional shares of Zentalis Pharmaceuticals as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Zentalis Pharmaceuticals, in just a few clicks!
Returns in Zentalis Pharmaceuticals (ZNTL) for Indian investors in Rupees
The Zentalis Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
Investment Value
₹1,00,000
Zentalis Pharmaceuticals investment value today
Current value as on today
₹12,295
Returns
Returns from Zentalis Pharmaceuticals Stock
Dollar Returns
₹2,341 (+2.34%)
Indian investors sentiment towards Zentalis Pharmaceuticals (ZNTL)
Global Institutional Holdings in Zentalis Pharmaceuticals
Matrix Capital Management Company, LLC
19.44%
Eventide Asset Management, LLC
6.23%
BlackRock Inc
5.90%
Vanguard Group Inc
4.56%
Citadel Advisors Llc
4.48%
Decheng Capital LLC
3.26%
Analyst Recommendation on Zentalis Pharmaceuticals
Buy
82%Buy
17%Hold
0%Sell
Based on 17 Wall street analysts offering stock ratings for Zentalis Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Zentalis Pharmaceuticals Stock (ZNTL)
What analysts predicted
Upside of 362.53%
Target:
$5.97
Current:
$1.29
Insights on Zentalis Pharmaceuticals Stock (Ticker Symbol: ZNTL)
Price Movement
In the last 6 months, ZNTL stock has moved down by -59.9%ZNTL vs ONC (1 yr)
In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 166.4%ZNTL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 123.8%Price to Sales
ForZNTL every $1 of sales, investors are willing to pay $1.4, whereas for Beone Medicines Ltd, the investors are paying $6.4 for every $1 of sales.
Zentalis Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Zentalis Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.
Zentalis Pharmaceuticals (ZNTL) Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -30.77% | -59.69% | -90.05% | -94.38% | -94.65% |
 | -17.1% | -41.85% | -37.2% | -21.74% | -0.85% |
 | -13.12% | 5.03% | 78.34% | 40.23% | 43.44% |
 | -4.76% | 2.3% | 24.05% | 71.43% | 78.99% |
 | -9.09% | -19.67% | 62.43% | 39.66% | 61.91% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -2.25 | -0.43 | -0.24 | NA | 4.73 |
| 14.68 | 14.68 | 0.9 | 41.18 | 0.16 | 0.07 | 0.01 | 273.57 |
| NA | NA | NA | 1.09 | -0.19 | -0.06 | NA | 31.22 |
| 32.84 | NA | 1.34 | 17.96 | -0.03 | 0.13 | NA | 63.87 |
| NA | NA | -0.49 | 0.81 | -15.01 | -0.03 | NA | 0.52 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $92.6M | -94.65% | NA | -245.96% |
| Buy | $60.5B | -0.85% | 14.68 | 31.07% |
| NA | $26.9B | 43.44% | NA | -16.92% |
| Buy | $125.7B | 78.99% | 32.84 | -4.86% |
| Buy | $30.4B | 61.91% | NA | -12.37% |
About Zentalis Pharmaceuticals
Management People of Zentalis Pharmaceuticals
Important FAQs about investing in ZNTL Stock from India :
What is Zentalis Pharmaceuticals share price today?
Zentalis Pharmaceuticals share price today stands at $1.29, Open: $1.25 ; Previous Close: $1.26 ; High: $1.34 ; Low: $1.23 ; 52 Week High: $13.46 ; 52 Week Low: $1.01.
The stock opens at $1.25, after a previous close of $1.26. The stock reached a daily high of $1.34 and a low of $1.23, with a 52-week high of $13.46 and a 52-week low of $1.01.
Can Indians buy Zentalis Pharmaceuticals shares?
Yes, Indians can invest in the Zentalis Pharmaceuticals (ZNTL) from India.
With INDmoney, you can buy Zentalis Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Zentalis Pharmaceuticals at zero transaction cost.
How can I buy Zentalis Pharmaceuticals shares from India?
It is very easy to buy Zentalis Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Zentalis Pharmaceuticals (ZNTL) be purchased?
Yes, you can buy fractional shares of Zentalis Pharmaceuticals with INDmoney app.
What are the documents required to start investing in Zentalis Pharmaceuticals stocks?
To start investing in Zentalis Pharmaceuticals, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Zentalis Pharmaceuticals Stock (ZNTL)?
Today’s highest price of Zentalis Pharmaceuticals (ZNTL) is $1.34.
Today’s lowest price of Zentalis Pharmaceuticals (ZNTL) is $1.23.
What is today's market capitalisation of Zentalis Pharmaceuticals?
What is the 52 Week High and Low Range of Zentalis Pharmaceuticals Stock (ZNTL)?
52 Week High
$13.46
52 Week Low
$1.01
What are the historical returns of Zentalis Pharmaceuticals (ZNTL)?
1 Month Returns
-30.77%
3 Months Returns
-59.69%
1 Year Returns
-90.05%
5 Years Returns
-94.65%
Who is the Chief Executive Officer (CEO) of Zentalis Pharmaceuticals ?
Discover More
- Whitehawk Therapeutics Inc
$1.57
+1.95%
- Jpmorgan Climate Change Sols
$41.30
+0.72%
- Capital Group Conservative Equity Etf
$25.59
-0.05%
Gain Therapeutics Inc$1.80
+3.45%
Wisdomtree Intl Qlty Dvd Grw$35.27
+0.94%
Academy Veteran Impact Etf$19.73
-0.88%
Bny Mellon Ultra Short Income Etf$49.71
+0.05%
Spdr S&p Global Infrastructure Etf$63.13
+1.48%
Bicycle Therapeutics Plc$7.39
-1.34%